Convection-Enhanced Delivery of a First-in-Class Anti-β1 Integrin Antibody for the Treatment of High-Grade Glioma Utilizing Real-Time Imaging

Introduction: OS2966 is a first-in-class, humanized and de-immunized monoclonal antibody which targets the adhesion receptor subunit, CD29/β1 integrin. CD29 expression is highly upregulated in glioblastoma and has been shown to drive tumor progression, invasion, and resistance to multiple modalities...

Descripción completa

Detalles Bibliográficos
Autores principales: Nwagwu, Chibueze D., Immidisetti, Amanda V., Bukanowska, Gabriela, Vogelbaum, Michael A., Carbonell, Anne-Marie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7823464/
https://www.ncbi.nlm.nih.gov/pubmed/33396712
http://dx.doi.org/10.3390/pharmaceutics13010040

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7823464/
https://www.ncbi.nlm.nih.gov/pubmed/33396712
http://dx.doi.org/10.3390/pharmaceutics13010040

Ejemplares similares